Neurocrine Bioscience buy Bank of America Co.
Start price
07.02.25
/
50%
€125.40
Target price
07.02.26
€172.66
Performance (%)
-5.94%
End price
08.02.26
€117.95
Summary
This prediction ended on 08.02.26 with a price of €117.95. With a performance of -5.94%, the BUY prediction by Bank_of_America_Co_ finished with a loss. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -1.104% | -1.104% | 7.386% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Bank of America Co. from $184.00 to $179.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten